1. Home
  2. BCYC vs SPFI Comparison

BCYC vs SPFI Comparison

Compare BCYC & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • SPFI
  • Stock Information
  • Founded
  • BCYC 2009
  • SPFI 1941
  • Country
  • BCYC United Kingdom
  • SPFI United States
  • Employees
  • BCYC N/A
  • SPFI N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • SPFI Major Banks
  • Sector
  • BCYC Health Care
  • SPFI Finance
  • Exchange
  • BCYC Nasdaq
  • SPFI Nasdaq
  • Market Cap
  • BCYC 529.8M
  • SPFI 615.3M
  • IPO Year
  • BCYC 2019
  • SPFI 2019
  • Fundamental
  • Price
  • BCYC $7.10
  • SPFI $41.32
  • Analyst Decision
  • BCYC Buy
  • SPFI Buy
  • Analyst Count
  • BCYC 12
  • SPFI 3
  • Target Price
  • BCYC $22.91
  • SPFI $41.67
  • AVG Volume (30 Days)
  • BCYC 261.8K
  • SPFI 50.8K
  • Earning Date
  • BCYC 08-08-2025
  • SPFI 07-16-2025
  • Dividend Yield
  • BCYC N/A
  • SPFI 1.45%
  • EPS Growth
  • BCYC N/A
  • SPFI 19.09
  • EPS
  • BCYC N/A
  • SPFI 3.20
  • Revenue
  • BCYC $19,281,000.00
  • SPFI $199,001,000.00
  • Revenue This Year
  • BCYC $7.35
  • SPFI $13.41
  • Revenue Next Year
  • BCYC N/A
  • SPFI $6.10
  • P/E Ratio
  • BCYC N/A
  • SPFI $12.96
  • Revenue Growth
  • BCYC N/A
  • SPFI 7.49
  • 52 Week Low
  • BCYC $6.10
  • SPFI $30.01
  • 52 Week High
  • BCYC $28.67
  • SPFI $42.38
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.11
  • SPFI 66.23
  • Support Level
  • BCYC $7.25
  • SPFI $38.54
  • Resistance Level
  • BCYC $7.68
  • SPFI $39.72
  • Average True Range (ATR)
  • BCYC 0.42
  • SPFI 1.28
  • MACD
  • BCYC -0.07
  • SPFI 0.27
  • Stochastic Oscillator
  • BCYC 12.80
  • SPFI 95.74

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.

Share on Social Networks: